Comprehensive methylome map of lineage commitment from haematopoietic progenitors

Article metrics

Abstract

Epigenetic modifications must underlie lineage-specific differentiation as terminally differentiated cells express tissue-specific genes, but their DNA sequence is unchanged. Haematopoiesis provides a well-defined model to study epigenetic modifications during cell-fate decisions, as multipotent progenitors (MPPs) differentiate into progressively restricted myeloid or lymphoid progenitors. Although DNA methylation is critical for myeloid versus lymphoid differentiation, as demonstrated by the myeloerythroid bias in Dnmt1 hypomorphs1, a comprehensive DNA methylation map of haematopoietic progenitors, or of any multipotent/oligopotent lineage, does not exist. Here we examined 4.6 million CpG sites throughout the genome for MPPs, common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), granulocyte/macrophage progenitors (GMPs), and thymocyte progenitors (DN1, DN2, DN3). Marked epigenetic plasticity accompanied both lymphoid and myeloid restriction. Myeloid commitment involved less global DNA methylation than lymphoid commitment, supported functionally by myeloid skewing of progenitors following treatment with a DNA methyltransferase inhibitor. Differential DNA methylation correlated with gene expression more strongly at CpG island shores than CpG islands. Many examples of genes and pathways not previously known to be involved in choice between lymphoid/myeloid differentiation have been identified, such as Arl4c and Jdp2. Several transcription factors, including Meis1, were methylated and silenced during differentiation, indicating a role in maintaining an undifferentiated state. Additionally, epigenetic modification of modifiers of the epigenome seems to be important in haematopoietic differentiation. Our results directly demonstrate that modulation of DNA methylation occurs during lineage-specific differentiation and defines a comprehensive map of the methylation and transcriptional changes that accompany myeloid versus lymphoid fate decisions.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Examples of known lineage-related genes showing differential DNA methylation between lymphoid and myeloid progenitors.
Figure 2: Gene expression correlates strongly with DMRs at shores.
Figure 3: CHARM identified genes with previously unknown functions in lymphoid/myeloid lineage commitment and pluripotency maintenance.

References

  1. 1

    Bröske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nature Genet. 41, 1207–1215 (2009)

  2. 2

    Chao, M. P., Seita, J. & Weissman, I. L. Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb. Symp. Quant. Biol. 73, 439–449 (2008)

  3. 3

    Trowbridge, J. J., Snow, J. W., Kim, J. & Orkin, S. H. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5, 442–449 (2009)

  4. 4

    Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261–282 (1987)

  5. 5

    Irizarry, R. A. et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18, 780–790 (2008)

  6. 6

    Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet. 41, 1350–1353 (2009)

  7. 7

    Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Genet. 41, 178–186 (2009)

  8. 8

    Molina, T. J. et al. Profound block in thymocyte development in mice lacking p56lck. Nature 357, 161–164 (1992)

  9. 9

    Klebanoff, S. J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77, 598–625 (2005)

  10. 10

    Cacalano, G. et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682–684 (1994)

  11. 11

    Gupta, S. K., Gupta, M., Hoffman, B. & Liebermann, D. A. Hematopoietic cells from gadd45a-deficient and gadd45b-deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation and inflammation. Oncogene 25, 5537–5546 (2006)

  12. 12

    Barreto, G. et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445, 671–675 (2007)

  13. 13

    Rai, K. et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and Gadd45. Cell 135, 1201–1212 (2008)

  14. 14

    Engel, N. et al. Conserved DNA methylation in Gadd45a−/− mice. Epigenetics 4, 98–99 (2009)

  15. 15

    Bell, J. J. & Bhandoola, A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452, 764–767 (2008)

  16. 16

    Wada, H. et al. Adult T-cell progenitors retain myeloid potential. Nature 452, 768–772 (2008)

  17. 17

    Wei, S. M., Xie, C. G., Abe, Y. & Cai, J. T. ADP-ribosylation factor like 7 (ARL7) interacts with α-tubulin and modulates intracellular vesicular transport. Biochem. Biophys. Res. Commun. 384, 352–356 (2009)

  18. 18

    Chadwick, K., Shojaei, F., Gallacher, L. & Bhatia, M. Smad7 alters cell fate decisions of human hematopoietic repopulating cells. Blood 105, 1905–1915 (2005)

  19. 19

    King, A. G., Kondo, M., Scherer, D. C. & Weissman, I. L. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc. Natl Acad. Sci. USA 99, 4508–4513 (2002)

  20. 20

    Kondo, M. et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407, 383–386 (2000)

  21. 21

    Jin, C. et al. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2. Nature Struct. Mol. Biol. 13, 331–338 (2006)

  22. 22

    Popov, V. M. et al. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol. Metab. 21, 41–49 (2010)

  23. 23

    Pillay, L. M., Forrester, A. M., Erickson, T., Berman, J. N. & Waskiewicz, A. J. The Hox cofactors Meis1 and Pbx act upstream of gata1 to regulate primitive hematopoiesis. Dev. Biol. 340, 306–317 (2010)

  24. 24

    Hu, Y. L., Fong, S., Ferrell, C., Largman, C. & Shen, W. F. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis. Mol. Cell. Biol. 29, 5181–5192 (2009)

  25. 25

    Crable, S. C. & Anderson, K. P. A. PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene. Blood 101, 4757–4764 (2003)

  26. 26

    Du, Y., Jenkins, N. A. & Copeland, N. G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106, 3932–3939 (2005)

  27. 27

    Tadokoro, Y., Ema, H., Okano, M., Li, E. & Nakauchi, H. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J. Exp. Med. 204, 715–722 (2007)

  28. 28

    Claus, R., Almstedt, M. & Lubbert, M. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin. Oncol. 32, 511–520 (2005)

  29. 29

    Feinberg, A. P. & Irizarry, R. A. Evolution in Health and Medicine Sackler Colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc. Natl Acad. Sci. USA 107, 1757–1764 (2005)

  30. 30

    Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature advance online publication, 10.1038/nature09342 (19 July 2010)

Download references

Acknowledgements

We thank L. Jerabek for laboratory management, C. Richter and N. Teja for antibody production, A. Mosley, J. Dollaga and D. Escoto for animal care, E. Zuo and the Stanford PAN facility for microarray processing, and E. Briem and A. N. Allen for CHARM array processing. This investigation was supported by National Institutes of Health grants R37CA053458 and P50HG003233 (to A.P.F), R01AI047457 and R01AI047458 (to I.L.W.), and a grant from the Thomas and Stacey Siebel Foundation (to I.L.W). L.I.R.E. was supported by Special Fellow Career Development award from the Leukemia and Lymphoma Society; J.S. was supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001); D.J.R. was supported by National Institutes of Health grant R00AGO29760; M.A.I. was supported by National Institutes of Health grant CA09151 and a fellowship from the California Institute for Regenerative Medicine (T1-00001); T.S. was supported by a fellowship from the National Institutes of Health (F32AI058521).

Author information

H.J. performed genome-scale and gene-specific DNA methylation analysis; L.I.R.E. and J.S. performed cell-sorting, generated microarray datasets, and performed gene expression analysis; P.L. assisted L.I.R.E. and H.L. assisted H.J.; A.D. and H.J. performed statistical analysis with P.M., M.J.A. and R.A.I; D.J.R., M.A.I., T.S., H.K. and L.H. generated microarray datasets; A.P.F. and I.L.W. designed the experiment, and A.P.F., H.J., L.I.R.E. and J.S. wrote the paper with the assistance of K.K. and G.Q.D.

Correspondence to Andrew P. Feinberg.

Ethics declarations

Competing interests

I.L.W. has stock in Amgen and is co-founder of Cellerant Inc. and Stem Cells Inc. He is also a consultant for Stem Cells Inc. The other authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures S1-S7 with legends. Supplementary Table 1-3 were added on 28 September 2010. (PDF 6191 kb)

Supplementary Table 1

This table shows differentially methylated regions identified by CHARM. (XLS 3155 kb)

Supplementary Table 2

This table shows gene ontology functional categories enriched in identified differentially methylated regions. (XLS 357 kb)

Supplementary Table 3

This table shows primer sequences used for bisulfite pyrosequencing and location of CpG sites interrogated. Chromosomal coordinates are based on the UCSC Genome Browser Mouse Feb. 2006 (mm8). (XLS 42 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.